The grant will accelerate development of the product’s second clinical indication, according to a May 26 news release. Ortho Regenerative Technologies is behind orthobiologic products including Ortho-R.
Axelys is a nonprofit organization supporting public research and innovation.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.